NDC product
Xlear Nasal Decongestant
NDC 27017-018 · Xlear Inc.
Key facts
| Product NDC | 27017-018 |
|---|---|
| Proprietary name | Xlear Nasal Decongestant |
| Nonproprietary name | Nasal Spray |
| Substances | OXYMETAZOLINE HYDROCHLORIDE |
| Dosage form | LIQUID |
| Route | NASAL |
| Labeler | Xlear Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC] |
| Marketing start | Mar 12, 2019 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: